Meningococcal Polysaccharide Antigen Group W-135 Uses, Dosage, Side Effects and more

Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup W-135. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup W-135.

Attribute	Details
Trade Name	Meningococcal Polysaccharide Antigen Group W-135
Generic	Meningococcal polysaccharide vaccine group W-135
Meningococcal polysaccharide vaccine group W-135 Other Names	Meningococcal polysaccharide antigen group W-135, neisseria meningitidis group W-135 capsular polysaccharide antigen, Neisseria meningitidis group W-135 polysaccharide antigen, A
Type
Groups	Approved, Experimental, Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph